Paper48253
Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.
Hahn GM and 2 others. Proc Natl Acad Sci U S A, 1975. Cited by 508 papers, by iCite.
Cite this record
ConductScience Library. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Papers, record 48253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/48253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Doxorubicin | Major topic |
| Hot Temperature | Major topic |
| Mammary Neoplasms, Experimental | Major topic |
| Sarcoma, Experimental | Major topic |
| Animals | |
| Cell Line | |
| Cell Survival | |
| Cricetinae | |
| Mice | |
| Mice, Inbred BALB C | |
| Neoplasm Transplantation |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4121070 | Effect of bleomycin on mammalian cell survival. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4121070 | PubMed |
| 2 | 4121931 | Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4121931 | PubMed |
| 3 | 4122362 | A clinical review of bleomycin--a new antineoplastic agent. | Cancer | 1973 | https://conductscience.org/library/papers/4122362 | PubMed |
| 4 | 4128424 | Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents. | Cancer Chemother Rep | 1973 | https://conductscience.org/library/papers/4128424 | PubMed |
| 5 | 4138162 | Metabolic aspects of the role of hyperthermia im mammalian cell inactivation and their possible relevance to cancer treatment. | Cancer Res | 1974 | https://conductscience.org/library/papers/4138162 | PubMed |
| 6 | 4292219 | Selective heat sensitivity of cancer cells. Biochemical and clinical studies. | Cancer | 1967 | https://conductscience.org/library/papers/4292219 | PubMed |
| 7 | 4634086 | Thermal enhancement of thio-TEPA cytotoxicity. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4634086 | PubMed |
| 8 | 4695229 | Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. | Radiat Res | 1973 | https://conductscience.org/library/papers/4695229 | PubMed |
| 9 | 4748422 | Selective lethal effect of supranormal temperatures on mouse sarcoma cells. | Cancer Res | 1973 | https://conductscience.org/library/papers/4748422 | PubMed |
| 10 | 5481703 | Daunomycin metabolism in rat tissue slices. | J Pharmacol Exp Ther | 1970 | https://conductscience.org/library/papers/5481703 | PubMed |
| 11 | 5541516 | Molecular motion in spin-labeled phospholipids and membranes. | J Am Chem Soc | 1971 | https://conductscience.org/library/papers/5541516 | PubMed |
| 12 | 5761385 | Chinese hamster cell monolayer cultures. I. Changes in cell dynamics and modifications of the cell cycle with the period of growth. | Exp Cell Res | 1968 | https://conductscience.org/library/papers/5761385 | PubMed |
| 13 | 5794423 | Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. | Tetrahedron Lett | 1969 | https://conductscience.org/library/papers/5794423 | PubMed |
| 14 | 5929561 | Chromosome aberrations induced by thymidine. | Exp Cell Res | 1966 | https://conductscience.org/library/papers/5929561 | PubMed |
| 15 | 5953301 | New antibiotics, bleomycin A and B. | J Antibiot (Tokyo) | 1966 | https://conductscience.org/library/papers/5953301 | PubMed |
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 508 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41708120 | Present and future of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for pleural metastases: a narrative review. | Eur Respir Rev | 2026 | https://conductscience.org/library/papers/41708120 | PubMed |
| 41083760 | Recent advances in metallic nanostructure-based photothermal therapy in the management of cancer metastasis. | Med Oncol | 2025 | https://conductscience.org/library/papers/41083760 | PubMed |
| 38534622 | Development of pH-Responsive, Thermosensitive, Antibacterial, and Anticancer CS/PVA/Graphene Blended Hydrogels for Controlled Drug Delivery. | Gels | 2024 | https://conductscience.org/library/papers/38534622 | PubMed |
| 37559173 | Photothermal-Triggered Sulfur Oxide Gas Therapy Augments Type I Photodynamic Therapy for Potentiating Cancer Stem Cell Ablation and Inhibiting Radioresistant Tumor Recurrence. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37559173 | PubMed |
| 36233653 | The Role of Intraperitoneal Intraoperative Chemotherapy with Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis from Ovarian Cancer-Hyperthermia versus Normothermia: A Randomized Controlled Trial. | J Clin Med | 2022 | https://conductscience.org/library/papers/36233653 | PubMed |
| 35540837 | A pH and magnetic dual-response hydrogel for synergistic chemo-magnetic hyperthermia tumor therapy. | RSC Adv | 2018 | https://conductscience.org/library/papers/35540837 | PubMed |
| 33803677 | 880 nm NIR-Triggered Organic Small Molecular-Based Nanoparticles for Photothermal Therapy of Tumor. | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/33803677 | PubMed |
| 33483518 | A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy. | Nat Commun | 2021 | https://conductscience.org/library/papers/33483518 | PubMed |
| 32917589 | Novel fractionated ultrashort thermal exposures with MRI-guided focused ultrasound for treating tumors with thermosensitive drugs. | Sci Adv | 2020 | https://conductscience.org/library/papers/32917589 | PubMed |
| 32887622 | Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer. | J Nanobiotechnology | 2020 | https://conductscience.org/library/papers/32887622 | PubMed |
| 31696114 | Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment. | Front Bioeng Biotechnol | 2019 | https://conductscience.org/library/papers/31696114 | PubMed |
| 31462676 | Pulsed-wave Ultrasound Hyperthermia Enhanced Nanodrug Delivery Combined with Chloroquine Exerts Effective Antitumor Response and Postpones Recurrence. | Sci Rep | 2019 | https://conductscience.org/library/papers/31462676 | PubMed |
| 31448377 | Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast Cancer. | Nanoscale Res Lett | 2019 | https://conductscience.org/library/papers/31448377 | PubMed |
| 31345068 | Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia. | Int J Hyperthermia | 2019 | https://conductscience.org/library/papers/31345068 | PubMed |
| 30226898 | Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study. | PLoS One | 2018 | https://conductscience.org/library/papers/30226898 | PubMed |
| 30128039 | Thermo- and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo-photothermal therapy against subcutaneous and metastatic breast tumors. | Theranostics | 2018 | https://conductscience.org/library/papers/30128039 | PubMed |
| 30001990 | Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/30001990 | PubMed |
| 29659611 | Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series. | PLoS One | 2018 | https://conductscience.org/library/papers/29659611 | PubMed |
| 29479833 | Clinical outcomes of radio-hyperthermo-chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched-pair cohort study. | Cancer Med | 2018 | https://conductscience.org/library/papers/29479833 | PubMed |
| 29266476 | Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy. | Adv Mater | 2018 | https://conductscience.org/library/papers/29266476 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/48253
GET https://conductscience.org/api/papers/v1/48253/cited_by?page=2